Publication: Polypyridyl CoII-Curcumin Complexes as Photoactivated Anticancer and Antibacterial Agents
dc.contributor.author | Yadav, Ashish Kumar | |
dc.contributor.author | Singh, Virendra | |
dc.contributor.author | Kushwaha, Rajesh | |
dc.contributor.author | Dolui, Dependu | |
dc.contributor.author | Rai, Rohit | |
dc.contributor.author | Dhar, Prodyut | |
dc.contributor.author | Dutta, Arnab | |
dc.contributor.author | Koch, Biplob | |
dc.contributor.author | Banerjee, Samya | |
dc.date.accessioned | 2025-01-28T09:46:33Z | |
dc.date.available | 2025-01-28T09:46:33Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Four new CoII complexes, [Co(bpy)2(acac)]Cl (1), [Co(phen)2(acac)]Cl (2), [Co(bpy)2(cur)]Cl (3), [Co(phen)2(cur)]Cl (4), where bpy=2,2�-bipyridine (1 and 3), phen=1,10-phenanthroline (2 and 4), acac=acetylacetonate (1 and 2), cur=curcumin monoanion (3 and 4) have been designed, synthesized and fully characterized. The X-ray crystal structures of 1 and 2 indicated that the CoN4O2 core has a distorted octahedral geometry. The photoactivity of these complexes was tuned by varying the ? conjugation in the ligands. Curcumin complexes 3 and 4 had an intense absorption band near 435 nm, which made them useful as visible-light photodynamic therapy agents; they also showed fluorescence with ?em?565 nm. This fluorescence was useful for studying their intracellular uptake and localization in MCF-7 breast cancer cells. The acetylacetonate complexes (1 and 2) were used as control complexes to understand the role of curcumin. The white-light-triggered anticancer profiles of the cytosol targeting complexes 3 and 4 were investigated in detail. These non-dark toxic complexes displayed significant apoptotic photo-cytotoxicity (under visible light) against MCF-7 cells through ROS generation. The control complexes 1 and 2 did not induce significant cell death in the light or dark. Interestingly, 1-4 produced a remarkable antibacterial response upon light exposure. Overall, the reported results here can increase the boundary of the CoII-based anticancer and antibacterial drug development. � 2023 Wiley-VCH GmbH. | |
dc.identifier.doi | https://doi.org/10.1002/cbic.202300033 | |
dc.identifier.issn | 14394227 | |
dc.identifier.uri | https://dl.bhu.ac.in/ir/handle/123456789/22343 | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc | |
dc.subject | anticancer agents | |
dc.subject | antimicrobial agents | |
dc.subject | Co<sup>II</sup> complexes | |
dc.subject | curcumin-based complexes | |
dc.subject | photosensitizers | |
dc.title | Polypyridyl CoII-Curcumin Complexes as Photoactivated Anticancer and Antibacterial Agents | |
dc.type | Article | |
dspace.entity.type | Publication | |
journal.title | ChemBioChem | |
journalvolume.identifier.volume | 24 |